— Know what they know.
Not Investment Advice

NXTG.TA TLV

Nextage Therapeutics Ltd
1W: +8.4% 1M: +20.5% 3M: -11.0% YTD: -12.0% 1Y: -62.6% 3Y: -58.3% 5Y: -93.0%
₪38.70 ($0.13)
-0.10 (-0.26%)
 
TLV · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 56 · ₪31.4M mcap · 6M float · 1.18% daily turnover

Balance Sheet Trends

Total Assets
$353K -67.8% ▼
5Y CAGR: -43.3%
Total Liabilities
$6M +53.7% ▲
5Y CAGR: +20.2%
Shareholders Equity
-$6M -90.2% ▼
Cash & Investments
$253K -37.4% ▼
5Y CAGR: -25.2%
Total Debt
$210K -44.4% ▼
Net Debt
$210K +907.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$2M$3M$1M$404K$0
Short-Term Investments$35K$99K$0$0$253K
Cash & ST Investments$2M$3M$1M$404K$253K
Net Receivables$435K$684K$197K$142K$61K
Inventory$0$0$0$0$0
Other Current Assets-$35K-$73K$0$253K$0
Total Current Assets$3M$4M$1M$886K$317K
Property, Plant & Equip.$240K$116K$89K$209K$36K
Goodwill & Intangibles$1M$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$2M$116K$89K$209K$36K
Total Assets$4M$4M$2M$1M$353K
— Liabilities —
Accounts Payable$208K$446K$136K$124K$243K
Short-Term Debt$194K$202K$211K$232K$163K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$280K$813K$875K$1M$2M
Total Current Liabilities$2M$3M$2M$4M$6M
Long-Term Debt$550K$1M$123K$0$0
Other Non-Current Liab.$538K$66K$43K$36K$36K
Total Non-Current Liabilities$1M$1M$166K$106K$36K
Total Liabilities$3M$4M$2M$4M$6M
— Equity —
Common Stock$24M$30M$56M$61M$0
Retained Earnings-$22M-$30M-$35M-$39M-$43M
Accumulated OCI$0$0$0-$26M-$26M
Total Stockholders Equity$1M-$253K-$895K-$3M-$6M
Total Liabilities & Equity$4M$4M$2M$1M$353K
— Key Metrics —
Total Debt$841K$1M$334K$378K$210K
Net Debt-$1M-$2M-$717K-$26K$210K
Total Investments$35K$99K$0$0$253K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms